Biocracked
Approach 4, conceptual metaphor, in palette D, bold color field.

A single glass beaker-shaped water carafe sits at center frame on a saturated tangerine-orange seamless backdrop, photographed straight-on at slight low angle. The carafe is filled with clear water, and a small, cleanly drilled hole near its base releases a thin, steady stream that falls into a shallow white ceramic dish below, with a few droplets frozen mid-air. This stands for NAD+ draining away through a leak. A tiny electric green (#00e676) rubber stopper is held by a gloved fingertip entering from the right, about to plug the hole. Lighting is crisp, high-key studio light from upper left, giving sharp specular highlights on the glass and soft, warm-neutral shadows on the backdrop. Mood: clever, precise, optimistic but skeptical. No text or labels.
Longevity

Wanda ke Satar NAD+ a Kwakwalwarka: Yadda Hana CD38 ke Ɗaga Matakin NAD+ a Kwakwalwa

Nova Chen · · 5 min read

Idan Ka Saya NMN ko NR Don Cika Tankin NAD+ ɗinka, Ga Wani Tambaya Mai Taushi

Idan ka sayi NMN ko NR don cika tankin NAD+ ɗinka, wani sabon bincike na gwaji ya tambaya wani abu mai ban mamaki: me zai faru idan tankin yana da rami? Ramin da ake magana akansa shi ne wani enzyme da ake kira CD38. A dabbobin beraye da linzami, maganin da ke toshe CD38 ya ƙara matakin NAD+ a kwakwalwa kuma ya sauƙaƙa matsalolin motsi a samfurin cutar Parkinson.

Kafin kowa ya yanke shawarar sayar da kayayyakin kari, ga abin da ya kamata a sani. Wannan maganin da ake magana akansa shi ne CVN14, wani magani na gwaji daga kamfanin Cerevance. Ba kari ba ne, ba a sayar da shi ga masu amfani ba, kuma an gudanar da aikin ne a cikin beraye, linzami da ƙwayoyin sel, ba a mutane ba.

Menene "Masanin Satar NAD+"?

NAD+ wani cofactor ne da ƙwayoyin sel ke buƙata don ayyuka da dama. Yana raguwa da tsufa, kuma marubutan sun nuna dalilai biyu: ƙasa da ƙirƙirar NAD+ da kuma ƙaruwa da cinye shi. CD38 na ɗaya daga cikin enzymes da ke cinye NAD+ (NADase), kuma yawan sa yana ƙaruwa da tsufa da cuta. Masu binciken sun yi ikirarin cewa wannan yana ɗaya daga cikin abubuwan da ke haifar da ragin NAD+ da ya shafi shekaru. Haka kuma sun lura da alaƙar gado tsakanin CD38 da cutar Parkinson (PD), wanda ya ba su ƙwarin gwiwa su bincika wannan a cikin wannan yanayin.

Ta amfani da bayanan NETSseq daga samfuran kwakwalwa na mutum da aka samu bayan mutuwa, ƙungiyar ta gano cewa CD38 yana yawaita a cikin astrocytes, waɗanda su ne ƙwayoyin tallafi masu siffar tauraro a kwakwalwa. Neurons ba su ne wurin da aka fi samun wannan enzyme ba.

Muhimmin Sakamako: Hana CD38, NAD+ a Kwakwalwa Ya Ɗaga

CVN14 magani ne da ke shiga cikin kwakwalwa, mai zaɓin hana CD38 wanda ƙungiyar ta taƙaita a baya. A wannan takarda sun bayyana shi a cikakke.

  • Karfi: Ya hana CD38 na recombinant da ƙimar IC50 na 19.0 nM (mutum), 5.1 nM (beraye), da 2.4 nM (linzami). Ƙananan lamba na nufin ƙarfi mafi girma, don haka ya fi tasiri a kan enzyme na linzami kuma mafi rauni – amma har yanzu mai ƙarfi – a kan na mutum.
  • Zaɓi: Ba shi da aiki a kan CD157, ɗan'uwa mafi kusa da CD38, ko kuma a kan wasu NADases.
  • NAD+ a Kwakwalwa: Ya ƙara NAD+ a kwakwalwar beraye da linzami.
  • Kula da Knockout: Bai yi wani tasiri ba a berayen da aka yi musu knockout na CD38. Wannan yana tallafa wa ra'ayin cewa ƙaruwa na NAD+ ya samo asali ne daga toshe CD38, ba daga wani enzyme mai cinye NAD+ ba.

Takaitaccen bayanin ba ya ba da adadin ƙaruwa na NAD+, don haka babu wani ƙididdiga na kashi a nan.

Mahangar Parkinson

Masu binciken sun gwada ko wannan ƙaruwa na NAD+ tana da tasiri a cikin samfurin cutar Parkinson, wadda ke da alamar taruwar ƙwayar α‑synuclein da ba ta da tsari.

A cikin ƙwayoyin sel: A cikin ƙwayoyin mesencephalic na beraye da aka ƙalubale da α‑synuclein, CVN14 ya nuna alamar ƙara tsawon rayuwar ƙwayoyin dopamine. Waɗannan su ne ƙwayoyin da ke mutuwa a PD. Har wa yau ya rage yawan ƙwayoyin da ke ɗauke da pSer129 α‑synuclein, alamar ƙwayar da ke da matsala. Marubutan sun ce wannan yana ba da goyon baya ga ci gaba da bincike kan rawar da hana CD38 zai iya takawa wajen kawar da ƙwayar da ke haifar da cuta. Sun yi magana cikin kulawa, kuma ya kamata a karanta haka.

A cikin beraye: A cikin samfurin berayen da aka yi amfani da AAV1/2‑hA53T α‑synuclein, CVN14 ya inganta aikin motsi a gwajin silinda (cylinder test). Wannan gwaji ne ɗaya na ɗabi'a a cikin samfurin dabbobi guda ɗaya.

Karanta Wannan Kafin Ka Yi Murna

Ƙuntatawa suna da yawa:

  • Babu bayanan mutum. Dukkan abin da aka ambata an samo su ne daga beraye, linzami, da ƙwayoyin sel, da kuma ƙwayoyin mutum da aka samu bayan mutuwa domin gano inda CD38 yake.
  • Kamfanin ya dauki kuɗi. Dukkan marubutan ma'aikata ne a Cerevance Ltd, wadda ke haɓaka maganin. Wannan ba yana nufin a ƙaryata aikin ba, amma yana tasiri kan yadda za a kimanta shi.
  • Gwaji ɗaya na ɗabi'a. Amfanin motsi an nuna shi ne a gwajin silinda kawai. Sakamakon ya tsaya a kan “bincike na gaba”.
  • Dangantaka a cikin binciken. Takardar tana nuna NAD+ na ƙaruwa da alamomin kariya ga ƙwayoyin a cikin tsarin guda. Ba ta tabbatar da cewa ƙaruwa na NAD+ ke haifar da ribar ba.
  • Babu ƙima ga mutane. Ba a ba da wani ƙima, lokaci, ko bayanin aminci ga kowa ba.

Abin Da Wannan Ke Nufi Ga Masu Siyan NMN da NR

Wannan takarda ba ta gwada NMN, NR, ko wani kari ba. Amma tana taimakawa wajen tunani kan yadda dabarun NAD+ za su iya aiki a nan gaba. Ga wasu mahimman abubuwa:

  1. NAD+ matsala ce ta samar‑da‑bukata. Abubuwan da ke ƙara NAD+ kamar NMN da NR su ne na bangaren samar. Hana CD38 kuwa na magance bangaren bukata. Idan CD38 babban mai cinye NAD+ ne a kwakwalwa mai tsufa, to ƙara samar kaɗai na iya zama rabi kawai na magani. Wannan ra'ayi ne daga wannan bincike, ba gaskiya ba ga masu amfani da kari.
  2. Hadin gwiwa ra'ayi ne da za a bi, ba tsarin ba. Haɗa maganin da ke ƙara NAD+ da maganin da ke toshe CD38 yana da jan hankali, amma wannan bincike bai gwada hakan ba, kuma babu shaidar mutum.
  3. Yi hattara da ikirarin "natural CD38 inhibitor". Wasu sun ce flavonoid kamar apigenin da quercetin su ne masu toshe CD38. Wannan ba daga wannan takarda ba, kuma tasirin su a kwakwalwar mutum ba a tabbatar ba. CVN14 an ƙirƙira shi musamman don zama mai zaɓi da kuma shiga kwakwalwa. Babu dalili na tunanin wani flavonoid daga abinci zai yi haka.
  4. Waɗanda ya shafa? A yanzu, ba kowa ba sai a cikin yanayin bincike. Manufar maganin ita ce cutar Parkinson da sauran cututtukan da ke da α‑synuclein, kuma har yanzu yana cikin matakin gwaji. Duk wanda ke da matsalar ƙwaƙwalwa ya kamata ya tuntuɓi likita maimakon ya yi ƙoƙarin magance kansa bisa ga bayanan beraye.
  5. Kima da lokaci. Ba a ba da wani ƙima ko jadawalin lokaci ga mutane ba, saboda babu.

Kammalawa

Binciken ya nuna a sarari cewa CD38, wanda ke yawaita a astrocytes a kwakwalwar mutum, yana ɗaukar matsayi mai ƙarfi a matsayin mai cinye NAD+ da ya kamata a nufa. Mai hana CD38 na zaɓi ya ƙara NAD+ a kwakwalwar dabbobi, kuma hakan ya faru ne kawai idan CD38 yana nan. A cikin samfurin Parkinson, an ga yana da alaƙa da tsawon rayuwar ƙwayoyin dopamine a ƙwayoyin sel, rage alamun α‑synuclein da ba su da tsari, da kuma inganta aikin motsi a beraye. Ko wannan zai iya tashi zuwa ga mutane ne tambaya ga gwaje‑gwajen da za su zo.

A yanzu, darasin da ya fi dacewa ga masoya NAD+ shi ne: yadda saurin cinye NAD+ ke tasiri na iya zama da mahimmanci kamar yadda yawan abin da ake ƙara.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

**Approach:** Conceptual metaphor. **Palette:** Bold color field (mustard yellow).

Straight-on, slightly elevated camera view of a pair of identical brass balance scales on a saturated mustard-yellow seamless backdrop. The pans sit perfectly level. One pan holds a small mound of fine white crystalline powder, the other holds an almost identical mound. A third, smaller pan lies tipped and lighter off to the side. Between the scales, a single translucent glass tube coils like a gut, with a tiny electric green (#00e676) glow inside it. This is the only green in the frame. Lighting is soft, directional studio light from the upper left, with crisp, gentle shadows on the yellow surface and warm metallic highlights on the brass. Mood: playful, curious, quietly skeptical. Photorealistic with sharp macro detail on the powder grain and the glass.
supplements

NMN da NR: Binciken Ɗan Adam Ya Gano Daidaito da Sauyin Hanjin

BY NOVA CHEN ·

Shekaru da dama ana sayar da NMN a matsayin abin da yafi inganci fiye da NR. Binciken farko a kan mutane tsakanin NMN, NR da nicotinamide ya nuna cewa duka biyun masu tsada suna haifar da ƙaruwa daidai a matakin NAD+ a jini, yayin da nicotinamide ba ta yi ba. Abin ban mamaki kuwa, ƙwayoyin hanji suna mayar da NR da NMN zuwa nicotinic acid, wadda ke ƙara NAD+ sosai a gwaje‑gwajen jini. Wannan na haifar da tambayoyi masu rikitarwa game da farashi, niacin da kuma microbiome ɗinka. Ga abin da binciken mutane 65 ya nuna da kuma abin da ba ya nuna, tare da iyakokin makonni 14 na nazari mai budaddiyar alama da Nestlé ta tallafa.

Approach 1, macro science, in palette D, bold color field.

Extreme close-up microscopy-style image of a single mouse oocyte, a translucent spherical egg, shot straight on at its equator. Inside the cytoplasm, hundreds of mitochondria appear as tiny glowing grains. Most are a muted grey-amber, while a scattered subset of small and large organelles glows vivid electric green (#00e676), clustered unevenly to suggest an uneven response. Fine granular cumulus cells cling to the egg's edge, slightly out of focus. The backdrop is a saturated, flat magenta-violet field, with soft rim light wrapping the egg's glassy membrane and shallow depth of field blurring the edges. The mood is quiet, precise and slightly uneasy, a closer look revealing what the averages hid. Photoreal confocal-meets-studio look, with no text and no labels.
longevity

NMN Ya Sabunta Mitochondria Da Aka ɓoye a cikin Ƙwai Masu Tsufa, Amma Ba daidai ba

BY NOVA CHEN ·

Binciken da aka yi a kan ƙwai na beraye masu tsufa ya nuna cewa a nazari na gaba ɗaya mitochondria suna kama da na ƙwai matasa, amma idan an rarrabe su, an gano ƙungiyoyi biyu na musamman da ke ƙara yawan mtDNA da tsufa. NMN yana mayar da waɗannan ƙungiyoyin zuwa matakin ƙwai matasa, yayin da yake rage yawan mtDNA a manyan mitochondria. Binciken ba ya ƙunshi sakamakon haihuwa, kuma an gudanar da shi ne a beraye ne kawai, tare da wasu marubuta da ke da alaƙa da kamfanoni. Wannan shi ne abin da ke nufin, da abin da ba ya nufi, ga mata da ke tunanin amfani da NMN don ƙara yawan ɗa.

Approach: Macro science (tissue). Palette: B, warm.

Extreme macro photograph in the style of a microscopy image, showing a cluster of rounded, translucent golden fat cells (adipocytes) in the foreground. Fine strands of pale pink-red muscle fibers run diagonally across the frame behind them. Between the two tissues, tiny glistening droplets drift along a thin capillary, suggesting a signal travelling from fat to muscle. Shot at a slight low angle with shallow depth of field, so the foreground cells are crisp and the muscle fibers melt into soft blur. Lit by warm amber backlight that makes the fat cells glow like honey, with copper-toned shadows and a faint rim of light on the fiber edges. One small electric green fluorescent speck sits inside a single droplet as the only cool accent. The mood is quiet, curious and intimate, with a sense of hidden communication inside the body.
longevity

Saƙon Da Mai Kitse Ke Fitarwa Zai Iya Kariya Ga Tsoka Idan NAD+ Ya Ɗaga

BY NOVA CHEN ·

Yawancin masu shan NMN ko NR suna tunanin ƙara NAD+ zai yi aiki kai tsaye a cikin ƙwayoyin tsoka. Sai dai wani sabon binciken berayen da aka wallafa a *Cell Metabolism* ya nuna cewa kitse na iya zama ɓangaren da aka ɓoye, inda yake sakin sinadirin kariya da ake kira Serpina3n zuwa jini. Wannan saƙon yana ba da kariya ga tsoka a yanayin tsufa, rashin motsa jiki, da kuma cutar sankara. Duk da haka, binciken na dabbobi ne kawai, marubutan sun nema haƙƙin mallaka, kuma ba a nuna amfanin ko ƙimar da ta dace ga mutane ba.

Approach: conceptual metaphor. Palette: D, bold color field.

A single dented red-orange bicycle pump-style hand bellows is not needed; instead, show a translucent glass bell jar standing on a saturated mustard-yellow seamless backdrop, photographed at a slight low three-quarter angle. Inside the jar, a real anatomical-looking sheep heart model in matte deep red sits slightly shrunken-looking under a thin, half-deflated clear balloon, suggesting low oxygen pressure. Beside the jar, a small cracked-open glass ampoule of white powder spills a tiny pale dusting onto the surface, with one thin electric green ribbon tied around the jar's knob. Soft studio key light from the upper left, crisp hard-edged shadow falling to the right, subtle glass reflections. Mood: puzzled, analytical, mixed result, tense but clean.
supplements

NMN a ƙarƙashin ƙarancin oxygen: Ba ya ceton zuciya, amma yana da wasu tasiri

BY NOVA CHEN ·

NMN ana yawan gabatar da shi a matsayin kariya ga ƙwayoyin sel, amma me ke faruwa idan ƙwayoyin suna fama da ƙarancin oxygen na lokaci‑lokaci? Binciken da aka yi a kan berayen a shekarar 2026, kuma aka wallafa a *Nutrients*, ya nuna cewa NMN ba ya hana girman zuciya da hypoxia ke haifarwa. Sai dai, ya rage wasu alamun damuwar zuciya (BNP da Myh7), ya daidaita ma’aunin alwara, kuma ya canza ƙwayoyin halittar hanji. A gefe guda kuma, ya ƙara matakin LDH a jini, don haka sakamakon ya kasance mai rikitarwa kuma ba a iya ɗauka a matsayin kariya ba. Anan za mu fayyace abin da takardar ta nuna, abin da ba ta nuna ba, da dalilin da ya sa wannan bincike aka yi a dabbobi kawai – don haka ba a ba da shawarar canza tsarin shan ƙarin ba tukuna.

This page is available in